Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Gac Med Mex ; 153(Supl. 2): S13-S17, 2017.
Article in Spanish | MEDLINE | ID: mdl-29099107

ABSTRACT

Objective: To evaluate the impact of the implementation of the Infarction Code strategy in patients with acute myocardial infarction diagnosis. Methods: Consecutive patients with ST-elevation acute myocardial infarction ≤12 hours of evolution, were included in the infarction code strategy, before (Group I) and after (Group II). Times of medical attention and major cardiovascular events during hospitalization were analyzed. Results: 1227 patients were included, 919 men (75%) and 308 women (25%) with an average age of 62 ± 11 years. Among Group I and Group II, percutaneous coronary intervention reperfusion therapy changed (16.6% to 42.6%), fibrinolytic therapy (39.3% to 25%), and patients who did not receive any form of reperfusion therapy (44% to 32.6%; p < 0.0001). Times of medical attention decreased significantly (door-to-needle time decreased from 92 to 72 minutes, p = 0.004; door-to-balloon time decreased from 140 to 92 minutes, p < 0.0001). Kidney failure (24.6% vs. 17.9%; p = 0.006), major complications (35.3% to 29.3%), and death (21% vs. 12%; odds ratio: 0.52; 95% confidence interval: 0.38-0.71; p = 0.004). also decreased. Conclusion: The Infarction Code strategy improved treatment, times of medical attention and decreased complications and death in these patients.


Subject(s)
Angioplasty, Balloon, Coronary/statistics & numerical data , Percutaneous Coronary Intervention/statistics & numerical data , ST Elevation Myocardial Infarction/classification , ST Elevation Myocardial Infarction/therapy , Thrombolytic Therapy/statistics & numerical data , Aged , Female , Humans , Male , Mexico , Middle Aged , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , ST Elevation Myocardial Infarction/complications , ST Elevation Myocardial Infarction/mortality , Time Factors , Time-to-Treatment/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...